Currently, it is almost impossible to diagnose a patient at the onset of
sepsis due to the lack of real-time metrics with high sensitivity and specificity. The
purpose of the present study is to determine the diagnostic value of model-based insulin
sensitivity (SI) as a new sepsis biomarker in critically ill patients, and compare its
performance to classical inflammatory parameters. (Copied from article).